Understanding the Current Rating
MarketsMOJO’s 'Sell' rating for TTK Healthcare Ltd. is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. This rating suggests that investors should exercise caution with this stock, as the current outlook indicates challenges that may impact returns and risk profiles. The rating was adjusted on 21 Jul 2025, reflecting a shift in the company’s overall assessment, but the following analysis uses the latest data available as of 25 May 2026 to provide a clear picture of the stock’s present condition.
Quality Assessment
As of 25 May 2026, TTK Healthcare Ltd. holds an average quality grade. This indicates that while the company maintains a stable operational base, it lacks the robust growth drivers or exceptional financial health that would elevate it to a higher quality tier. Over the past five years, the company’s net sales have grown at a modest annual rate of 6.99%, while operating profit has expanded at a more encouraging 15.42% per annum. Despite this, the growth trajectory is considered insufficiently strong to inspire confidence in sustained outperformance.
Valuation Perspective
Currently, the stock’s valuation is deemed attractive. This suggests that the market price may be undervalued relative to the company’s earnings potential and asset base. Attractive valuation can often present buying opportunities; however, in the case of TTK Healthcare Ltd., this positive aspect is tempered by other factors such as flat financial trends and technical weakness. Investors should weigh the valuation against the broader context of the company’s performance and sector dynamics before making investment decisions.
Financial Trend Analysis
The financial grade for TTK Healthcare Ltd. is flat, reflecting a lack of significant improvement or deterioration in recent periods. The latest half-year data reveals some concerning signs: cash and cash equivalents have dropped to a low of ₹600.89 crores, and the debtors turnover ratio stands at a low 7.40 times, indicating potential inefficiencies in receivables management. Additionally, non-operating income constitutes a substantial 80.43% of profit before tax in the latest quarter, which may raise questions about the sustainability of earnings from core operations.
Technical Outlook
The technical grade is mildly bearish, signalling that the stock’s price momentum and chart patterns currently suggest downward pressure. This is corroborated by recent stock returns: as of 25 May 2026, TTK Healthcare Ltd. has declined by 0.27% in one day, 0.66% over one week, and 3.16% in one month. More notably, the stock has fallen 19.73% over six months and 30.95% over the past year, consistently underperforming the BSE500 benchmark in each of the last three annual periods. Such trends highlight investor caution and a lack of positive technical catalysts.
Stock Returns and Market Position
The stock’s performance metrics as of 25 May 2026 paint a challenging picture. Year-to-date, the stock has lost 13.97%, and over the last year, it has delivered a negative return of 30.95%. This persistent underperformance relative to the broader market index underscores the risks associated with holding the stock at present. Furthermore, domestic mutual funds hold a negligible stake of just 0.01%, which may reflect limited institutional confidence or interest in the company’s prospects.
Investor Implications
For investors, the 'Sell' rating on TTK Healthcare Ltd. signals caution. While the stock’s valuation appears attractive, the combination of average quality, flat financial trends, and bearish technical signals suggests that the company faces headwinds that could constrain capital appreciation. Investors should consider these factors carefully and may wish to prioritise stocks with stronger fundamentals and more favourable technical setups.
Summary of Key Metrics as of 25 May 2026
- Mojo Score: 42.0 (Sell grade)
- Net Sales Growth (5 years CAGR): 6.99%
- Operating Profit Growth (5 years CAGR): 15.42%
- Cash and Cash Equivalents (HY): ₹600.89 crores
- Debtors Turnover Ratio (HY): 7.40 times
- Non-Operating Income (Quarterly): 80.43% of PBT
- 1-Year Stock Return: -30.95%
- YTD Stock Return: -13.97%
- Domestic Mutual Fund Holding: 0.01%
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Conclusion
TTK Healthcare Ltd.’s current 'Sell' rating by MarketsMOJO reflects a cautious stance grounded in the company’s average quality, attractive but insufficient valuation, flat financial trends, and mildly bearish technical outlook. The stock’s recent performance and limited institutional interest further reinforce the need for prudence. Investors should monitor the company’s operational improvements and market conditions closely before considering exposure, as the current environment suggests limited upside potential and elevated risks.
53% Discount is LIVE - Get MojoOne + Stock of the Week for 3 Years Start Today
